LAUSR

Trimethylamine N‐oxide (TMAO) is associated with overall mortality in patients with chronic kidney disease (CKD). Previous findings suggest that P. frutescens (L.) can alleviate renal injury, but its effects and mechanisms underlying alleviation of TMAO‐induced kidney damage remain unclear. In this study, a TMAO injury model, in vivo and in vitro, was established to clarify the effects and mechanisms of P. frutescens in alleviating TMAO‐induced kidney injury. The results show that TMAO (60 mM/L) can induce the activation of apoptosis signal‐regulating kinase 1 (ASK1)‐c‐Jun N‐terminal kinase (JNK), thus aggravating downstream cell apoptosis in vitro. The study also found that P. frutescens aqueous extract (PFAE) (5 mg/mL) can inhibit TMAO‐induced apoptosis by downregulating ASK1‐JNK phosphorylation. In the in vivo experiments, it was demonstrated that TMAO can increase the levels of blood urea nitrogen and cystatin C, aggravating renal tubular epithelial apoptosis. The results also show that PFAE can reduce TMAO‐induced renal damage by inhibiting ASK1‐JNK phosphorylation in vivo. Our findings confirmed that P. frutescens can alleviate TMAO‐induced renal tubule apoptosis by regulating ASK1‐JNK phosphorylation, indicating that P. frutescens may be an effective treatment for alleviating TMAO damage in CKD.